SFI
Susquehanna Fundamental Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-56,585
| Closed | -$13.3M | – | 1063 |
|
|
2024
Q4 | $13.3M | Buy |
+56,585
| New | +$13.3M | 0.19% | 134 |
|
|
2024
Q2 | $13.8M | Sell |
56,585
-31,482
| -36% | -$7.65M | 0.32% | 93 |
|
|
2024
Q1 | $13.2M | Buy |
+88,067
| New | +$13.2M | 0.61% | 38 |
|
|
2022
Q1 | $2.32M | Buy |
14,180
+7,892
| +126% | +$1.29M | 0.05% | 524 |
|
|
2021
Q4 | $1.07M | Hold |
6,288
| – | – | 0.03% | 627 |
|
|
2021
Q3 | $1.19M | Hold |
6,288
| – | – | 0.02% | 795 |
|
|
2021
Q2 | $1.07M | Sell |
6,288
-17,733
| -74% | -$3.01M | 0.02% | 829 |
|
|
2021
Q1 | $3.39M | Buy |
+24,021
| New | +$3.39M | 0.06% | 462 |
|
|
2020
Q4 | – | Sell |
-7,596
| Closed | -$1.11M | – | 1481 |
|
|
2020
Q3 | $1.11M | Buy |
+7,596
| New | +$1.11M | 0.03% | 605 |
|